Skip to main content

Table 1 Studies included in analysis

From: Discovering gene expression signatures responding to tyrosine kinase inhibitor treatment in chronic myeloid leukemia

Study

GEO dataset

The number of samples

Cell type/Tissue

Drug

Platform

Responder

Non-responder

McWeeney et al., 2010 [15]

GSE14671

41

18

CD34+ cell/BM

Imatinib

HG-U133_Plus_2

Crossman et al., 2005 [6]

GSE2535

16

12

White cell/Blood, BM

Imatinib

HG-U95Av2

Silveira et al., 2013 [16]

GSE33224

6

8

PBMC/Peripheral Blood

Dasatinib

Agilent-014850